IMMUNE THROMBOCYTOPENIC PURPURA
Clinical trials for IMMUNE THROMBOCYTOPENIC PURPURA explained in plain language.
Never miss a new study
Get alerted when new IMMUNE THROMBOCYTOPENIC PURPURA trials appear
Sign up with your email to follow new studies for IMMUNE THROMBOCYTOPENIC PURPURA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene-Edited cells take aim at stubborn autoimmune diseases
Disease control Not yet recruitingThis early-stage trial is testing a new treatment called CTX112 for adults with two serious autoimmune blood disorders: immune thrombocytopenia (ITP) and warm autoimmune hemolytic anemia (wAIHA). These conditions cause the immune system to attack the body's own blood cells. CTX11…
Matched conditions: IMMUNE THROMBOCYTOPENIC PURPURA
Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated May 26, 2026 06:24 UTC
-
Fatigue in ITP linked to poor fitness? new study to find out.
Knowledge-focused Not yet recruitingThis study looks at how physically fit children, teens, and young adults (ages 8–25) with chronic immune thrombocytopenic purpura (ITP) are. Researchers will measure their oxygen use during exercise and compare it to healthy kids. The goal is to see if fatigue and lower fitness a…
Matched conditions: IMMUNE THROMBOCYTOPENIC PURPURA
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated May 26, 2026 06:25 UTC
-
AI tool aims to predict heart risks in rare blood disorder patients
Knowledge-focused Not yet recruitingThis study will develop an artificial intelligence (AI) tool to help doctors decide the best heart treatment for people who have both immune thrombocytopenia (ITP) and coronary artery disease. Researchers will analyze data from 600 patients to predict the risk of major heart prob…
Matched conditions: IMMUNE THROMBOCYTOPENIC PURPURA
Sponsor: Xiao Hui Zhang • Aim: Knowledge-focused
Last updated May 07, 2026 18:39 UTC